RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medipal Holdings Stock

Medipal Holdings Stocks 2024

Medipal Holdings Stocks

211.78 M

Ticker

7459.T

ISIN

JP3268950007

WKN

897036

In 2024, Medipal Holdings had 211.78 M outstanding stocks, a -2.11% change from the 216.35 M stocks in the previous year.

The Medipal Holdings Stocks history

YEARNUMBER OF STOCKS (undefined JPY)
2027e211.78
2026e211.78
2025e211.78
2024211.78
2023216.35
2022223.12
2021223.06
2020229.02
2019236
2018231.82
2017226.44
2016226.44
2015226.19
2014226
2013227
2012235
2011235
2010236
2009240
2008235
2007232
2006217
2005196

Medipal Holdings shares outstanding

The number of shares was Medipal Holdings in 2023 — This indicates how many shares 216.346 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Medipal Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Medipal Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Medipal Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Medipal Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Medipal Holdings Aktienanalyse

What does Medipal Holdings do?

Medipal Holdings Corp is a leading Japanese company operating in various areas of the healthcare industry. Founded in 1995, the company has emerged as a key player in the Japanese healthcare sector and beyond. The company operates in different sectors to offer a wide range of products and services. These segments include wholesale and retail distribution of pharmaceuticals and healthcare products, hospital management, pharmaceutical manufacturing and medical technology, as well as pharmaceutical research and development. Medipal Holdings Corp's business model is to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. The company aims to provide a broad range of healthcare products and services that meet the needs of patients and healthcare providers. The pharmaceutical and healthcare products segment has made the company one of the leading distributors in Japan. Medipal Holdings Corp is a key partner for international companies looking to enter the Japanese market. This segment works closely with various medical facilities to ensure the smooth distribution of drugs and products. It also operates a retail chain of pharmacies that focuses on patient consultation. Hospital management is another important segment of Medipal Holdings Corp. The company is a major operator of hospitals in Japan and also operates senior facilities in the country. It is committed to high-quality medical care and improving the patient experience in its facilities. The company has also developed a program for international patients to meet the needs of foreign patients. The manufacturing of pharmaceuticals and medical technology is another important part of Medipal Holdings Corp's business. The company produces generics and also has partnerships with international pharmaceutical companies for the import and distribution of pharmaceutical products. Medipal Holdings Corp also invests in the research and development of new drugs and medical technology. The pharmaceutical research and development segment is one of Medipal Holdings Corp's newest initiatives. The company invests in the research of new drugs and medical technologies to expand its offering of healthcare products and services. It has its own research and development center as well as partnerships with other companies and institutions. In summary, Medipal Holdings Corp is a key player in the Japanese healthcare industry. The company has developed a wide range of healthcare products and services to meet the needs of patients and healthcare providers. It aims to provide a complete supply chain in the healthcare industry, ranging from the manufacturing of pharmaceuticals and medical technology to the supply of doctors and hospitals. Medipal Holdings Corp has a strong position in the pharmaceutical and healthcare products market as well as in hospital management, and is committed to improving the patient experience and researching new healthcare products. Medipal Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Medipal Holdings's Shares Outstanding

Medipal Holdings's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Medipal Holdings’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Medipal Holdings’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Medipal Holdings’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Medipal Holdings stock

How many stocks are there of Medipal Holdings?

The current number of stocks of Medipal Holdings is 211.78 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Medipal Holdings are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Medipal Holdings evolved in recent years?

The number of shares of Medipal Holdings has increased by -2.11% gesunken compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Medipal Holdings as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Medipal Holdings?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Medipal Holdings pay?

Over the past 12 months, Medipal Holdings paid a dividend of 60 JPY . This corresponds to a dividend yield of about 2.37 %. For the coming 12 months, Medipal Holdings is expected to pay a dividend of 62.18 JPY.

What is the dividend yield of Medipal Holdings?

The current dividend yield of Medipal Holdings is 2.37 %.

When does Medipal Holdings pay dividends?

Medipal Holdings pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Medipal Holdings?

Medipal Holdings paid dividends every year for the past 23 years.

What is the dividend of Medipal Holdings?

For the upcoming 12 months, dividends amounting to 62.18 JPY are expected. This corresponds to a dividend yield of 2.45 %.

In which sector is Medipal Holdings located?

Medipal Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipal Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipal Holdings from 12/1/2024 amounting to 30 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Medipal Holdings pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Medipal Holdings in the year 2023?

In the year 2023, Medipal Holdings distributed 53 JPY as dividends.

In which currency does Medipal Holdings pay out the dividend?

The dividends of Medipal Holdings are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medipal Holdings

Our stock analysis for Medipal Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medipal Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.